18-Fluorodeoxyglucose PET in Patients with Active Myelopathy

Eoin Flanagan, M.D., an Assistant Professor of Neurology and a Fellow in Autoimmune Neurology at Mayo Clinic in Rochester, MN, discusses his article appearing in the November 2013 issue of Mayo Clinic Proceedings, which suggests that PET scans may give a clue to the underlying etiology in patients with spinal cord disease.


Created by

Mayo Clinic